Willow Biosciences Inc. (WLLW.TO)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.55 Million CAD | -33.41% |
| 2022 | 19.22 Million CAD | -17.53% |
| 2021 | 23.3 Million CAD | 38.27% |
| 2020 | 16.85 Million CAD | 28.86% |
| 2019 | 13.08 Million CAD | 687.33% |
| 2018 | 1.66 Million CAD | 164.2% |
| 2017 | 628.86 Thousand CAD | -28.03% |
| 2016 | 873.73 Thousand CAD | 21.16% |
| 2015 | 721.12 Thousand CAD | -22.11% |
| 2014 | 925.8 Thousand CAD | -10.86% |
| 2013 | 1.03 Million CAD | 65.9% |
| 2012 | 626.07 Thousand CAD | -32.64% |
| 2011 | 929.42 Thousand CAD | -5.12% |
| 2010 | 979.54 Thousand CAD | -52.97% |
| 2009 | 2.08 Million CAD | 98.8% |
| 2008 | 1.04 Million CAD | -49.45% |
| 2007 | 2.07 Million CAD | 392.54% |
| 2006 | 420.82 Thousand CAD | -4.93% |
| 2005 | 442.64 Thousand CAD | 128.57% |
| 2004 | 193.65 Thousand CAD | 132.63% |
| 2003 | 83.24 Thousand CAD | 18.75% |
| 2002 | 70.1 Thousand CAD | -57.74% |
| 2001 | 165.86 Thousand CAD | -7.84% |
| 2000 | 179.96 Thousand CAD | 57.27% |
| 1999 | 114.43 Thousand CAD | -43.38% |
| 1998 | 202.12 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.15 Million CAD | -11.93% |
| 2024 Q2 | 2.11 Million CAD | 14.9% |
| 2023 Q2 | 3.78 Million CAD | -26.44% |
| 2023 Q1 | 5.14 Million CAD | -4.64% |
| 2023 Q4 | 2.44 Million CAD | -16.0% |
| 2023 Q3 | 2.91 Million CAD | -23.0% |
| 2023 FY | 12.79 Million CAD | -33.41% |
| 2022 FY | 19.22 Million CAD | -17.53% |
| 2022 Q2 | 4.76 Million CAD | -2.09% |
| 2022 Q3 | 4.19 Million CAD | -12.06% |
| 2022 Q4 | 5.39 Million CAD | 28.65% |
| 2022 Q1 | 4.86 Million CAD | -25.3% |
| 2021 Q3 | 6.16 Million CAD | 4.67% |
| 2021 FY | 23.3 Million CAD | 38.27% |
| 2021 Q1 | 4.74 Million CAD | 1.21% |
| 2021 Q2 | 5.88 Million CAD | 24.2% |
| 2021 Q4 | 6.51 Million CAD | 5.78% |
| 2020 FY | 16.85 Million CAD | 28.86% |
| 2020 Q1 | 4.25 Million CAD | -12.13% |
| 2020 Q4 | 4.68 Million CAD | 20.4% |
| 2020 Q2 | 3.99 Million CAD | -6.13% |
| 2020 Q3 | 3.88 Million CAD | -2.57% |
| 2019 FY | 13.08 Million CAD | 687.33% |
| 2019 Q3 | 4.27 Million CAD | 24.55% |
| 2019 Q2 | 3.43 Million CAD | 5723.3% |
| 2019 Q1 | 59 Thousand CAD | -72.09% |
| 2019 Q4 | 4.84 Million CAD | 13.12% |
| 2018 FY | 1.66 Million CAD | 164.2% |
| 2018 Q4 | 211.41 Thousand CAD | -14.48% |
| 2018 Q3 | 247.2 Thousand CAD | 49.46% |
| 2018 Q2 | 165.4 Thousand CAD | 9.72% |
| 2018 Q1 | 150.75 Thousand CAD | -7.12% |
| 2017 Q3 | 150.38 Thousand CAD | 12.22% |
| 2017 Q4 | 162.31 Thousand CAD | 7.93% |
| 2017 FY | 628.86 Thousand CAD | -28.03% |
| 2017 Q1 | 183.73 Thousand CAD | -5.89% |
| 2017 Q2 | 134.01 Thousand CAD | -27.06% |
| 2016 Q2 | 223.34 Thousand CAD | 54.69% |
| 2016 Q3 | 360.76 Thousand CAD | 61.53% |
| 2016 Q4 | 195.22 Thousand CAD | -45.89% |
| 2016 FY | 873.73 Thousand CAD | 21.16% |
| 2016 Q1 | 144.37 Thousand CAD | -18.88% |
| 2015 Q4 | 177.99 Thousand CAD | 1.47% |
| 2015 Q3 | 175.4 Thousand CAD | -20.58% |
| 2015 Q2 | 220.84 Thousand CAD | 17.06% |
| 2015 Q1 | 188.66 Thousand CAD | -1.79% |
| 2015 FY | 721.12 Thousand CAD | -22.11% |
| 2014 Q2 | 296.54 Thousand CAD | 35.19% |
| 2014 FY | 925.8 Thousand CAD | -10.86% |
| 2014 Q1 | 219.35 Thousand CAD | -26.95% |
| 2014 Q4 | 192.1 Thousand CAD | -40.74% |
| 2014 Q3 | 324.19 Thousand CAD | 9.32% |
| 2013 Q4 | 300.27 Thousand CAD | 34.98% |
| 2013 Q2 | 163.73 Thousand CAD | -13.2% |
| 2013 Q3 | 222.46 Thousand CAD | 35.87% |
| 2013 Q1 | 188.62 Thousand CAD | 28.74% |
| 2013 FY | 1.03 Million CAD | 65.9% |
| 2012 Q4 | 146.51 Thousand CAD | 15.17% |
| 2012 FY | 626.07 Thousand CAD | -32.64% |
| 2012 Q3 | 127.21 Thousand CAD | -24.83% |
| 2012 Q2 | 169.23 Thousand CAD | -16.95% |
| 2012 Q1 | 203.77 Thousand CAD | 10.73% |
| 2011 Q3 | 372.4 Thousand CAD | 66.21% |
| 2011 FY | 929.42 Thousand CAD | -5.12% |
| 2011 Q4 | 184.02 Thousand CAD | -50.58% |
| 2011 Q1 | 178.93 Thousand CAD | -35.49% |
| 2011 Q2 | 224.05 Thousand CAD | 25.22% |
| 2010 Q3 | 299.19 Thousand CAD | -19.77% |
| 2010 FY | 979.54 Thousand CAD | -52.97% |
| 2010 Q1 | 237.99 Thousand CAD | -79.49% |
| 2010 Q2 | 372.93 Thousand CAD | 56.7% |
| 2010 Q4 | 277.35 Thousand CAD | -7.3% |
| 2009 Q2 | 186.62 Thousand CAD | -41.32% |
| 2009 Q4 | 1.16 Million CAD | 272.56% |
| 2009 Q1 | 318.01 Thousand CAD | 68.01% |
| 2009 FY | 2.08 Million CAD | 98.8% |
| 2009 Q3 | 311.49 Thousand CAD | 66.91% |
| 2008 FY | 1.04 Million CAD | -49.45% |
| 2008 Q1 | 276.67 Thousand CAD | -27.79% |
| 2008 Q4 | 189.28 Thousand CAD | -46.51% |
| 2008 Q3 | 353.84 Thousand CAD | -70.4% |
| 2008 Q2 | 1.19 Million CAD | 332.09% |
| 2007 Q1 | 56.25 Thousand CAD | -26.89% |
| 2007 FY | 2.07 Million CAD | 392.54% |
| 2007 Q4 | 383.14 Thousand CAD | 76.19% |
| 2007 Q3 | 217.45 Thousand CAD | 4.83% |
| 2007 Q2 | 207.44 Thousand CAD | 268.77% |
| 2006 Q4 | 76.94 Thousand CAD | -4.03% |
| 2006 FY | 420.82 Thousand CAD | -4.93% |
| 2006 Q1 | 117.81 Thousand CAD | 580.13% |
| 2006 Q2 | 280.97 Thousand CAD | 138.5% |
| 2006 Q3 | 80.17 Thousand CAD | -71.46% |
| 2005 FY | 442.64 Thousand CAD | 128.57% |
| 2005 Q1 | 28.96 Thousand CAD | -56.11% |
| 2005 Q2 | 63.55 Thousand CAD | 119.41% |
| 2005 Q3 | 26.53 Thousand CAD | -58.25% |
| 2005 Q4 | 17.32 Thousand CAD | -34.71% |
| 2004 Q3 | 35.14 Thousand CAD | -3.31% |
| 2004 Q4 | 65.99 Thousand CAD | 87.75% |
| 2004 Q2 | 36.35 Thousand CAD | 133.1% |
| 2004 Q1 | 15.59 Thousand CAD | 2.6% |
| 2004 FY | 193.65 Thousand CAD | 132.63% |
| 2003 FY | 83.24 Thousand CAD | 18.75% |
| 2003 Q4 | 15.2 Thousand CAD | -5.6% |
| 2003 Q3 | 16.1 Thousand CAD | -16.66% |
| 2003 Q2 | 19.32 Thousand CAD | -14.24% |
| 2003 Q1 | 22.52 Thousand CAD | -12.53% |
| 2002 Q1 | 35.89 Thousand CAD | -15.08% |
| 2002 FY | 70.1 Thousand CAD | -57.74% |
| 2002 Q2 | 23.59 Thousand CAD | -34.28% |
| 2002 Q4 | 25.75 Thousand CAD | 906.45% |
| 2002 Q3 | 2559.00 CAD | -89.15% |
| 2001 Q2 | 64.91 Thousand CAD | 29.65% |
| 2001 Q3 | 64.1 Thousand CAD | -1.25% |
| 2001 FY | 165.86 Thousand CAD | -7.84% |
| 2001 Q4 | 42.27 Thousand CAD | -34.06% |
| 2001 Q1 | 50.06 Thousand CAD | 46.9% |
| 2000 Q4 | 34.08 Thousand CAD | 10.28% |
| 2000 FY | 179.96 Thousand CAD | 57.27% |
| 2000 Q3 | 30.9 Thousand CAD | 0.0% |
| 1999 FY | 114.43 Thousand CAD | -43.38% |
| 1998 FY | 202.12 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | 95.235% |
| Avicanna Inc. | 14.59 Million CAD | 48.231% |
| Avant Brands Inc. | 5.65 Million CAD | -33.486% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | 74.425% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | 38.685% |
| Knight Therapeutics Inc. | 155.54 Million CAD | 95.143% |
| MediPharm Labs Corp. | 23.08 Million CAD | 67.275% |
| OrganiGram Holdings Inc. | 277.81 Million CAD | 97.281% |
| Canopy Growth Corporation | 308.61 Million CAD | 97.552% |
| Auxly Cannabis Group Inc. | 40.28 Million CAD | 81.247% |